AI, wearable technology collaborate to predict health problems

Researchers from the University of Waterloo in Ontario, Canada, have developed artificial intelligence (AI) capable of using wearable-collected data to predict the onset of health problems. Findings were published Feb. 23 in the Journal of Applied Physiology.

The study aimed to outline a possible foundation for wearable technology and AI could partner to predict illness. Researchers hope the technology pairing could assess changes in aerobic responses to identify the onset of respiratory or cardiovascular disease.

"The onset of a lot of chronic diseases, including type 2 diabetes and chronic obstructive pulmonary disease, has a direct impact on our aerobic fitness," said first author Thomas Beltrame, of the Institute of Computing in University of Campinas in Brazil, and colleagues. "In the near future, we believe it will be possible to continuously check your health, even before you realize that you need medical help."

The study included healthy males in their 20s who wore a shirt for four days with sensors measuring heart rate, breathing and movement. Researchers were then able to compare the collected data readings with laboratory responses to predict benchmarks in daily activities.

“In conclusion, aerobic system dynamics can be investigated during unsupervised activities of daily living by wearable sensors,” concluded Beltrame and colleagues. “Although speculative, these algorithms have the potential to be incorporated into wearable systems for early detection of changes in health status in realistic environments by detecting changes in aerobic response dynamics.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.